Aveanna Healthcare Holdings Inc (AVAH)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ
Market Cap: $2.51B
Last updated: Nov 17, 2026 at 11:04 AM ET
Aveanna Healthcare Holdings Inc (AVAH) Financials: Revenue, Profit and Cash Flow
Aveanna Healthcare Holdings reported revenue of $2.43B for the fiscal year ended Dec 31, 2025, up 20.2% from the year before. That year, net income was $225.03M with a net margin of 9.2%, operating cash flow was $125.86M and free cash flow was $118.41M. The quarter ended Sep 30, 2026 had revenue of $695.54M and net income of $45.45M.
Revenue and Margins
The operating margin was 10.9% in the fiscal year ended Dec 2025, the highest of the 8 years shown. Over the 7 years to Dec 2025, revenue grew from $1.25B, a compound annual rate of 10.0%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.43B | +20.2% | 33.1% | 10.9% | 9.2% |
| Dec 2024 | $2.02B | +6.8% | 31.4% | 6.9% | -0.5% |
| Dec 2023 | $1.90B | +6.0% | 31.4% | 0.4% | -7.1% |
| Dec 2022 | $1.79B | +6.5% | 30.9% | -35.9% | -37.0% |
| Dec 2021 | $1.68B | +12.3% | 32.3% | -2.2% | -7.0% |
| Dec 2020 | $1.50B | +8.0% | 30.4% | -0.2% | -3.8% |
| Dec 2019 | $1.38B | +10.4% | 30.3% | 2.8% | -5.5% |
| Dec 2018 | $1.25B | N/A | 31.5% | 3.1% | -3.8% |
Income Statement
In the fiscal year ended Dec 2025, net income turned positive after a loss the year before. In the quarter ended Sep 2026, net income rose 223.3% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.43B | $2.02B | $1.90B | $1.79B | $1.68B | $1.50B | $1.38B | $1.25B |
| Cost of revenue | $1.63B | $1.39B | $1.30B | $1.23B | $1.14B | $1.04B | $964.81M | $859.35M |
| Gross profit | $805.15M | $635.54M | $595.43M | $553.23M | $542.40M | $454.51M | $419.25M | $394.32M |
| Operating income | $265.38M | $139.79M | $8.07M | -$642.28M | -$36.11M | -$3.49M | $38.95M | $39.03M |
| Net income | $225.03M | -$10.93M | -$134.52M | -$662.03M | -$117.04M | -$57.05M | -$76.52M | -$47.15M |
| EBITDA | $279.02M | $187.38M | $39.17M | -$525.06M | -$17.95M | $61.47M | $44.28M | $96.11M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $695.54M | $670.48M | $647.91M | $662.48M | $621.94M | $589.55M | $559.22M | $519.87M | $509.02M | $504.96M | $490.65M | $478.84M |
| Gross profit | $226.76M | $218.53M | $202.38M | $210.57M | $200.22M | $210.80M | $183.56M | $171.72M | $159.70M | $158.27M | $145.85M | $148.45M |
| Operating income | $83.56M | $79.98M | $75.94M | $77.27M | $56.27M | $80.03M | $51.80M | $45.77M | $34.02M | $37.13M | $22.87M | $29.29M |
| Net income | $45.45M | $40.29M | $41.65M | $178.75M | $14.06M | $27.02M | $5.19M | $29.18M | -$42.84M | $13.91M | -$11.17M | -$25.74M |
Balance Sheet
As of Dec 2025, total debt of $1.49B exceeded cash and equivalents by $1.29B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $2.01B | $1.66B | $1.61B | $1.71B | $2.33B | $1.84B | $1.58B | $1.55B |
| Current assets | $560.23M | $392.67M | $314.89M | $269.75M | $279.21M | $340.64M | $186.34M | $214.93M |
| Cash and equivalents | $193.26M | $84.29M | $43.94M | $19.22M | $30.49M | $137.34M | $3.33M | $8.00M |
| Total liabilities | $1.82B | $1.79B | $1.74B | $1.72B | $1.70B | $1.58B | $1.31B | $1.21B |
| Short-term debt | $200.44M | $198.60M | $183.04M | $28.45M | $27.25M | $24.67M | $20.86M | $9.40M |
| Long-term debt | $1.29B | $1.27B | $1.28B | $1.28B | $1.23B | $1.16B | $31.50M | N/A |
| Shareholder equity | $195.19M | -$122.09M | -$127.44M | -$4.17M | $637.95M | $267.17M | $270.94M | $344.99M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.21B | $2.11B | $2.02B | $2.01B | $1.81B | $1.77B | $1.66B | $1.66B | $1.64B | $1.66B | $1.64B | $1.61B |
| Total liabilities | $1.87B | $1.82B | $1.78B | $1.82B | $1.80B | $1.78B | $1.76B | $1.79B | $1.80B | $1.78B | $1.78B | $1.74B |
| Cash and equivalents | $197.84M | $97.20M | $189.27M | $193.26M | $145.87M | $100.74M | $71.49M | $84.29M | $78.46M | $47.66M | $42.61M | $43.94M |
| Shareholder equity | $337.42M | $287.28M | $240.05M | $195.19M | $9.91M | -$11.26M | -$98.67M | -$122.09M | -$154.98M | -$117.51M | -$134.14M | -$127.44M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 94.1% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $125.86M | $32.64M | $22.67M | -$48.40M | -$11.35M | $116.62M | -$8.71M | $21.60M |
| Capital expenditures | $7.45M | $6.32M | $6.12M | $12.01M | $15.95M | $15.24M | $16.64M | $19.58M |
| Free cash flow | $118.41M | $26.32M | $16.56M | -$60.41M | -$27.30M | $101.38M | -$25.35M | $2.02M |
| Investing cash flow | -$22.30M | -$6.32M | -$8.79M | -$25.29M | -$681.83M | -$193.54M | -$17.82M | -$229.55M |
| Financing cash flow | $5.41M | $14.03M | $10.85M | $62.42M | $586.33M | $210.94M | $21.86M | $204.15M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $72.25M | $80.93M | $4.35M | $49.72M | $33.20M | $51.57M | -$8.63M | $13.41M | $29.39M | $1.81M | -$11.97M | -$3.00M |
| Capital expenditures | $1.91M | $1.29M | $4.56M | $1.95M | $2.02M | $1.13M | $2.35M | $1.53M | $2.21M | $1.27M | $1.31M | $1.57M |
| Free cash flow | $70.34M | $79.64M | -$208.00K | $47.77M | $31.18M | $50.44M | -$10.98M | $11.88M | $27.18M | $540.00K | -$13.28M | -$4.57M |
Frequently Asked Questions About AVAH
What is Aveanna Healthcare Holdings' annual revenue?
Aveanna Healthcare Holdings reported revenue of $2.43B for the fiscal year ended Dec 31, 2025.
How fast is Aveanna Healthcare Holdings' revenue growing?
Revenue was up 20.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 10.8%.
Is Aveanna Healthcare Holdings profitable?
Yes. Aveanna Healthcare Holdings reported net income of $225.03M for the fiscal year ended Dec 31, 2025, with a net margin of 9.2%.
How much free cash flow does AVAH generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $125.86M minus capital expenditures of $7.45M produced free cash flow of $118.41M.
How much debt does Aveanna Healthcare Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.29B, short-term debt of $200.44M and cash and equivalents of $193.26M.
AVAH pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors